Emergency pharmacy order: lenalidomide 15MG and 2.5MG
Ended Awarded Last action
- Contract number
- 36C26126N0168
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $20,432
Award facts
- Contract value 100% obligated
- $20,432.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Boca Raton, FL 33432, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$0 | |
| Original award | $20,432 |
About this award
Exelan Pharmaceuticals Inc. was awarded an emergency delivery order valued at $20,432.31 for Lenalidomide 15mg and 2.5mg pharmaceutical products on October 9, 2025, by the Veterans Integrated Service Network 21 (VISN 21), a civilian component of the Department of Veterans Affairs. This firm fixed-price delivery order, which carries an ultimate completion date of December 31, 2025, was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract encompasses emergency pharmaceutical procurement with no set-aside designation, and performance will be executed in Boca Raton, Florida, where Exelan maintains its primary operations.
Exelan Pharmaceuticals Inc., a foreign-owned pharmaceutical manufacturer and distributor headquartered in Boca Raton, Florida, specializes in manufacturing, repackaging, and distributing generic and branded pharmaceutical products to federal healthcare systems, including the VA, Department of Defense, and Bureau of Prisons. This emergency order for Lenalidomide, a prescription medication used in treating multiple myeloma and certain lymphomas, reflects the company's established role as a critical pharmaceutical supplier to the VA system through multiple contract vehicles and long-term indefinite delivery contracts with ceiling values ranging into the millions of dollars. The award demonstrates the VA's reliance on Exelan's pharmaceutical distribution capabilities to meet urgent medication requirements for veteran healthcare delivery.
Quick answers
Who was awarded contract 36C26126N0168?
36C26126N0168 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on October 9, 2025.
How much is contract 36C26126N0168 worth?
The government has obligated $20,432 on 36C26126N0168.
Is contract 36C26126N0168 an order under another contract?
Yes. 36C26126N0168 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26126N0168 competed?
The extent of competition for 36C26126N0168 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award